Consolidated Income Statements - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues [Abstract]
Total revenue	$ 6,324,339	$ 5,966,072	$ 5,409,483
Expenses:
Salaries and benefits	2,657,700	2,534,756	2,384,062
Professional fees	1,192,645	1,097,119	980,270
Supplies	1,082,908	1,033,122	993,405
Other operating expenses	647,308	496,219	451,737
Government stimulus income	0	0	(8,463)
Interest expense	55,202	65,578	74,305
Depreciation and amortization	155,703	146,288	140,842
Loss on extinguishment and modification of debt	7,344	3,388	0
Other non-operating gains	(23,320)	(26,264)	(1,613)
Total operating expenses	6,037,981	5,603,012	5,257,869
Income before income taxes	286,358	363,060	151,614
Income tax expense	56,223	63,352	22,637
Net income	230,135	299,708	128,977
Net income attributable to noncontrolling interests	94,324	89,365	75,073
Net income attributable to Ardent Health, Inc.	$ 135,811	$ 210,343	$ 53,904
Net income per share:
Net income per common share, basic (in USD per share)	$ 0.96	$ 1.59	$ 0.43
Net income per common share, diluted (in USD per share)	$ 0.96	$ 1.58	$ 0.43
Weighted-average common shares outstanding:
Weighted average number of common shares, basic (in shares)	140,760,736	132,439,695	126,115,301
Weighted average number of common shares, diluted (in shares)	141,450,309	132,744,577	126,115,301
Nonrelated Party
Expenses:
Rents and leases	$ 109,586	$ 103,577	$ 97,444
Related Party
Expenses:
Rents and leases	$ 152,905	$ 149,229	$ 145,880